Summary
This randomised controlled trial, published in the Journal of the American College of Cardiology in 2016, evaluated hybrid coronary revascularisation—a combined approach using minimally invasive direct coronary artery bypass grafting and percutaneous coronary intervention—for patients with multivessel coronary artery disease. The study, led by Puskas and collaborators across multiple US cardiac centres, appears to assess whether this hybrid strategy offers clinical benefits compared to conventional approaches. The findings contribute to the evidence base for interventional cardiology practice in managing complex coronary disease.
UK applicability
Although this is a US-based clinical trial, the findings are relevant to UK cardiac surgery and interventional cardiology practice, where hybrid revascularisation techniques are increasingly adopted in specialist centres. Implementation would depend on NHS resource allocation and training availability in participating hospitals.
Key measures
Major adverse cardiovascular events, procedural success rates, follow-up clinical outcomes, safety metrics
Outcomes reported
The study evaluated the efficacy and safety of hybrid coronary revascularisation (combining minimally invasive direct coronary artery bypass with percutaneous coronary intervention) for treating multivessel coronary artery disease. Outcomes measured likely included procedural success, major adverse cardiovascular events, and clinical outcomes at follow-up.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.